pubmed.ncbi.nlm.nih.gov

Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study - PubMed

Clinical Trial

doi: 10.1007/BF02628672.

Affiliations

Clinical Trial

Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study

H H Fudenberg. Biotherapy. 1996.

Abstract

40 infantile autistic patients were studied. They ranged from 6 years to 15 years of age at entry. 22 were cases of classical infantile autism; whereas 18 lacked one or more clinical defects associated with infantile autism ("pseudo-autism"). Of the 22 with classic autism, 21 responded to transfer factor (TF) treatment by gaining at least 2 points in symptoms severity score average (SSSA); and 10 became normal in that they were main-streamed in school and clinical characteristics were fully normalized. Of the 18 remaining, 4 responded to TF, some to other therapies. After cessation of TF therapy, 5 in the autistic group and 3 of the pseudo-autistic group regressed, but they did not drop as low as baseline levels.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources